psoriasis
Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis Study Description   Brief Summary The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) …

A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants With Moderate-to-Severe Plaque Psoriasis Study Description   Brief Summary A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis Condition or Disease Psoriasis Study Design Study Type: Interventional (Clinical Trial) Estimated Enrollment: 3,040 Primary …